Actemra 200mg, a drug known scientifically as tocilizumab, represents a potent pharmaceutical agent primarily employed for the control of rheumatoid arthritis. This powerful compound functions by interfering with the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Additionally, Actemra has shown promise